We are live on ! Find out more
DC

DPM Capital Portfolio holdings

AUM $78.7M
1-Year Est. Return 2.71%
This Fund
S&P 500
This Quarter Est. Return
+26.35%
1 Year Est. Return
-2.71%
3 Year Est. Return
+109.84%
5 Year Est. Return
10 Year Est. Return
AUM
$131M
AUM Growth
+$12.7M
Cap. Flow
-$13.9M
Cap. Flow %
-10.61%
Top 10 Hldgs %
100%
Holding
8
New
4
Increased
2
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
DVA icon
DaVita
DVA
+$3.54M
2
AXTA icon
Axalta
AXTA
+$2.06M
3
DLTR icon
Dollar Tree
DLTR
+$335K
4
CAKE icon
Cheesecake Factory
CAKE
+$315K
5
ABMD
Abiomed Inc
ABMD
+$272K

Top Sells

Rank Stock Value
1
SYF icon
Synchrony
SYF
+$13.3M
2
PCRX icon
Pacira BioSciences
PCRX
+$7.4M

Sector Composition

Rank Sector Weight
1 Healthcare 81.75%
2 Financials 11.82%
3 Materials 5.77%
4 Consumer Staples 0.43%
5 Consumer Discretionary 0.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DVA icon
1
DaVita
DVA
$15.3B
$107M 81.56%
1,428,431
+53,332
+4% +$3.54M
SYF icon
2
Synchrony
SYF
$24.8B
$15.5M 11.82%
431,317
-372,147
-46% -$13.3M
AXTA icon
3
Axalta
AXTA
$7.66B
$7.58M 5.77%
249,427
+70,000
+39% +$2.06M
DLTR icon
4
Dollar Tree
DLTR
$24.6B
$300K 0.23%
+3,195
New +$335K
CAKE icon
5
Cheesecake Factory
CAKE
$5.12B
$297K 0.23%
+7,640
New +$315K
KHC icon
6
Kraft Heinz
KHC
$30.8B
$265K 0.2%
+8,240
New +$250K
ABMD
7
DELISTED
Abiomed Inc
ABMD
$250K 0.19%
+1,468
New +$272K
PCRX icon
8
Pacira BioSciences
PCRX
$1.03B
-194,262
Closed -$7.4M

Similar funds

DPM Capital's Q4 2019 Portfolio in Review

As of Q4 2019, DPM Capital held 8 positions worth $131M, up 11% from $119M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

DPM Capital withdrew a net $13.9M in Q4 2019, closing 1 position and reducing 1 holding. Its most notable exit was Pacira BioSciences, an estimated $7.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 82% of assets, up from 72% a quarter earlier, followed by Financials and Materials.

Against the trend, DPM Capital opened a new position in Dollar Tree worth $300K.

  • DPM Capital's largest Q4 2019 buy was Dollar Tree: 3,195 shares worth $300K.
  • DPM Capital added most to DaVita in Q4 2019, an estimated $3.54M increase.
  • DPM Capital's biggest Q4 2019 reduction was Synchrony, cutting an estimated $13.3M.
  • DPM Capital fully exited Pacira BioSciences in Q4 2019, selling an estimated $7.4M.
  • DPM Capital's ten largest holdings make up 100% of its $131M portfolio in Q4 2019.
  • DPM Capital opened 4 new positions and closed 1 in Q4 2019.
  • DPM Capital's portfolio value rose 11% quarter-over-quarter to $131M.

Based on DPM Capital's 13F filing for Q4 2019, filed 13 Feb 2020.